Cargando…
P1159: A MULTICENTER, INTERNATIONAL COLLABORATIVE STUDY EVALUATING FRONTLINE THERAPY WITH BENDAMUSTINE RITUXIMAB FOR WALDENSTRÖM MACROGLOBULINEMIA
| Autores principales: | , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9430342/ http://dx.doi.org/10.1097/01.HS9.0000847504.29146.b9 |
| _version_ | 1784779741179412480 |
|---|---|
| author | Zanwar, S. Abeykoon, J. Castillo, J. Durot, E. Kastritis, E. Uppal, E. Morel, P. Tawfiq, R. Montes, L. Paludo, J. Sarosiek, S. Kumar, S. Ogunbiyi, O. Cornillet-Lefebvre, P. Kyle, R. Delmer, A. Gertz, M. Dimopoulos, M. Ansell, S. Treon, S. D’Sa, S. Kapoor, P. |
| author_facet | Zanwar, S. Abeykoon, J. Castillo, J. Durot, E. Kastritis, E. Uppal, E. Morel, P. Tawfiq, R. Montes, L. Paludo, J. Sarosiek, S. Kumar, S. Ogunbiyi, O. Cornillet-Lefebvre, P. Kyle, R. Delmer, A. Gertz, M. Dimopoulos, M. Ansell, S. Treon, S. D’Sa, S. Kapoor, P. |
| author_sort | Zanwar, S. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9430342 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-94303422022-08-31 P1159: A MULTICENTER, INTERNATIONAL COLLABORATIVE STUDY EVALUATING FRONTLINE THERAPY WITH BENDAMUSTINE RITUXIMAB FOR WALDENSTRÖM MACROGLOBULINEMIA Zanwar, S. Abeykoon, J. Castillo, J. Durot, E. Kastritis, E. Uppal, E. Morel, P. Tawfiq, R. Montes, L. Paludo, J. Sarosiek, S. Kumar, S. Ogunbiyi, O. Cornillet-Lefebvre, P. Kyle, R. Delmer, A. Gertz, M. Dimopoulos, M. Ansell, S. Treon, S. D’Sa, S. Kapoor, P. Hemasphere Posters Lippincott Williams & Wilkins 2022-06-23 /pmc/articles/PMC9430342/ http://dx.doi.org/10.1097/01.HS9.0000847504.29146.b9 Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Posters Zanwar, S. Abeykoon, J. Castillo, J. Durot, E. Kastritis, E. Uppal, E. Morel, P. Tawfiq, R. Montes, L. Paludo, J. Sarosiek, S. Kumar, S. Ogunbiyi, O. Cornillet-Lefebvre, P. Kyle, R. Delmer, A. Gertz, M. Dimopoulos, M. Ansell, S. Treon, S. D’Sa, S. Kapoor, P. P1159: A MULTICENTER, INTERNATIONAL COLLABORATIVE STUDY EVALUATING FRONTLINE THERAPY WITH BENDAMUSTINE RITUXIMAB FOR WALDENSTRÖM MACROGLOBULINEMIA |
| title | P1159: A MULTICENTER, INTERNATIONAL COLLABORATIVE STUDY EVALUATING FRONTLINE THERAPY WITH BENDAMUSTINE RITUXIMAB FOR WALDENSTRÖM MACROGLOBULINEMIA |
| title_full | P1159: A MULTICENTER, INTERNATIONAL COLLABORATIVE STUDY EVALUATING FRONTLINE THERAPY WITH BENDAMUSTINE RITUXIMAB FOR WALDENSTRÖM MACROGLOBULINEMIA |
| title_fullStr | P1159: A MULTICENTER, INTERNATIONAL COLLABORATIVE STUDY EVALUATING FRONTLINE THERAPY WITH BENDAMUSTINE RITUXIMAB FOR WALDENSTRÖM MACROGLOBULINEMIA |
| title_full_unstemmed | P1159: A MULTICENTER, INTERNATIONAL COLLABORATIVE STUDY EVALUATING FRONTLINE THERAPY WITH BENDAMUSTINE RITUXIMAB FOR WALDENSTRÖM MACROGLOBULINEMIA |
| title_short | P1159: A MULTICENTER, INTERNATIONAL COLLABORATIVE STUDY EVALUATING FRONTLINE THERAPY WITH BENDAMUSTINE RITUXIMAB FOR WALDENSTRÖM MACROGLOBULINEMIA |
| title_sort | p1159: a multicenter, international collaborative study evaluating frontline therapy with bendamustine rituximab for waldenström macroglobulinemia |
| topic | Posters |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9430342/ http://dx.doi.org/10.1097/01.HS9.0000847504.29146.b9 |
| work_keys_str_mv | AT zanwars p1159amulticenterinternationalcollaborativestudyevaluatingfrontlinetherapywithbendamustinerituximabforwaldenstrommacroglobulinemia AT abeykoonj p1159amulticenterinternationalcollaborativestudyevaluatingfrontlinetherapywithbendamustinerituximabforwaldenstrommacroglobulinemia AT castilloj p1159amulticenterinternationalcollaborativestudyevaluatingfrontlinetherapywithbendamustinerituximabforwaldenstrommacroglobulinemia AT durote p1159amulticenterinternationalcollaborativestudyevaluatingfrontlinetherapywithbendamustinerituximabforwaldenstrommacroglobulinemia AT kastritise p1159amulticenterinternationalcollaborativestudyevaluatingfrontlinetherapywithbendamustinerituximabforwaldenstrommacroglobulinemia AT uppale p1159amulticenterinternationalcollaborativestudyevaluatingfrontlinetherapywithbendamustinerituximabforwaldenstrommacroglobulinemia AT morelp p1159amulticenterinternationalcollaborativestudyevaluatingfrontlinetherapywithbendamustinerituximabforwaldenstrommacroglobulinemia AT tawfiqr p1159amulticenterinternationalcollaborativestudyevaluatingfrontlinetherapywithbendamustinerituximabforwaldenstrommacroglobulinemia AT montesl p1159amulticenterinternationalcollaborativestudyevaluatingfrontlinetherapywithbendamustinerituximabforwaldenstrommacroglobulinemia AT paludoj p1159amulticenterinternationalcollaborativestudyevaluatingfrontlinetherapywithbendamustinerituximabforwaldenstrommacroglobulinemia AT sarosieks p1159amulticenterinternationalcollaborativestudyevaluatingfrontlinetherapywithbendamustinerituximabforwaldenstrommacroglobulinemia AT kumars p1159amulticenterinternationalcollaborativestudyevaluatingfrontlinetherapywithbendamustinerituximabforwaldenstrommacroglobulinemia AT ogunbiyio p1159amulticenterinternationalcollaborativestudyevaluatingfrontlinetherapywithbendamustinerituximabforwaldenstrommacroglobulinemia AT cornilletlefebvrep p1159amulticenterinternationalcollaborativestudyevaluatingfrontlinetherapywithbendamustinerituximabforwaldenstrommacroglobulinemia AT kyler p1159amulticenterinternationalcollaborativestudyevaluatingfrontlinetherapywithbendamustinerituximabforwaldenstrommacroglobulinemia AT delmera p1159amulticenterinternationalcollaborativestudyevaluatingfrontlinetherapywithbendamustinerituximabforwaldenstrommacroglobulinemia AT gertzm p1159amulticenterinternationalcollaborativestudyevaluatingfrontlinetherapywithbendamustinerituximabforwaldenstrommacroglobulinemia AT dimopoulosm p1159amulticenterinternationalcollaborativestudyevaluatingfrontlinetherapywithbendamustinerituximabforwaldenstrommacroglobulinemia AT ansells p1159amulticenterinternationalcollaborativestudyevaluatingfrontlinetherapywithbendamustinerituximabforwaldenstrommacroglobulinemia AT treons p1159amulticenterinternationalcollaborativestudyevaluatingfrontlinetherapywithbendamustinerituximabforwaldenstrommacroglobulinemia AT dsas p1159amulticenterinternationalcollaborativestudyevaluatingfrontlinetherapywithbendamustinerituximabforwaldenstrommacroglobulinemia AT kapoorp p1159amulticenterinternationalcollaborativestudyevaluatingfrontlinetherapywithbendamustinerituximabforwaldenstrommacroglobulinemia |